To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Ernie Strauss and Ronald Wakefield, who met through the patient navigation program of Northside Hospital, have built a ...

Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...

A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...

Ed O'Keefe is CBS News' senior White House and political correspondent reporting for all CBS News platforms. He's part of the team covering President Trump and covered all four years of Joe Biden's ...

When Hugh Lumby became an employment judge the cruel diease meant he could no longer speak. Here, he explains how he still delivers justice ...

Grade Group 5 (GG5) prostate cancer carries the poorest prognosis, yet it is often undetected at biopsy. We evaluate whether Cell Cycle Progression (CCP) score identifies biopsy-undetected GG5 disease ...

IsoPSA test offers improved prostate cancer risk stratification by analyzing PSA protein isoforms, enhancing specificity over traditional PSA tests. The test is included in key diagnostic guidelines, ...

John Eimen, a former child star known for his guest spot in "Leave it to Beaver," died Friday, Nov. 21, a representative confirmed. He was 76. Eimen died at his home in Mukilteo, Washington, from ...

Approaches to early detection of cancer often seem contentious, but the big-picture view is actually one of remarkable consensus. All major guideline groups recommend the Papanicolaou smear, ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer. Adding the drug enzalutamide to standard hormone therapy reduced the risk of ...